Inventor profile of:

Anders Nykjær

City:

Risskov

Country:

Denmark

Published Applications:

27

Last publication date:

2023-05-11

Top Assignees for applications by Anders Nykjær

The entities that hold a legal rights for patent applications filed by inventor Nykjær Anders:

Recent patent applications by Nykjær Anders

Anders Nykjær from Risskov, DK has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-05-11
US20230144901A1
Human necessities

SORTILIN ANTAGONISTS FOR USE IN THE TREATMENT OF DIABETIC RETINOPATHY

#2 | 2023-02-09
US20230044608A1
Chemistry; metallurgy

Compounds for treatment of eye diseases

#3 | 2017-11-02
US20170318057A1
Electricity

Modulation of the VPS10P-Domain Receptors for the Treatment of Cardiovascular Disease

#4 | 2017-08-24
US20170240611A1
Chemistry; metallurgy

Modulation of the VPS10p-Domain Receptor Family for the Treatment of Mental and Behavioural Disorders

#5 | 2017-06-08
US20170158766A1
Chemistry; metallurgy

Modulation of Activity of Neurotrophins

#6 | 2017-01-19
US20170014476A1
Human necessities

SorCS1 for the treatment of obesity

#7 | 2016-12-01
US20160349276A1
Physics

Use of Sortilin as Biomarker for Affective/Mood Disorders

#8 | 2016-03-03
US20160060346A1
Chemistry; metallurgy

Modulation of Activity of Proneurotrophins

#9 | 2016-01-21
US20160015778A1
Human necessities

SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto

#10 | 2015-10-22
US20150299304A1
Chemistry; metallurgy

Modulation of the VPS10P-Domain Receptors for the Treatment of Cardiovascular Disease

#11 | 2015-08-27
US20150239973A1
Chemistry; metallurgy

Modulation of the Interaction Between SorLA and GDNF-Family Ligand Receptors

#12 | 2015-08-20
US20150232565A1
Chemistry; metallurgy

Modulation of activity of neurotrophins

#13 | 2015-06-18
US20150166629A1
Chemistry; metallurgy

SorCS1 FOR USE IN THE TREATMENT OF OBESITY AND OVERWEIGHT

#14 | 2015-01-22
US20150023971A1
Chemistry; metallurgy

Modulation of activity of proneurotrophins

#15 | 2014-08-28
US20140242087A1
Chemistry; metallurgy

Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disorders

#16 | 2013-06-27
US20130164297A1
Human necessities

Modulation of activity of neurotrophins

#17 | 2013-05-09
US20130115212A1
Human necessities

Modulation of the Interaction between SorLA and GDNF-Family Ligand Receptors

#18 | 2012-08-16
US20120207721A1
Human necessities

SorCS1 for the treatment of obesity

#19 | 2012-06-21
US20120156183A1
Human necessities

SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto

#20 | 2012-04-05
US20120082671A1
Chemistry; metallurgy

Modulation of activity of neurotrophins

#21 | 2012-03-01
US20120052075A1
Chemistry; metallurgy

Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders

#22 | 2011-07-07
US20110166036A1
Chemistry; metallurgy

Modulation of the Vps10p-domain for the treatment of cardiovascular disease

#23 | 2011-06-16
US20110142830A1
Human necessities

Modulation of the TrpV: Vps10p receptor system for the treatment of pain

#24 | 2010-08-19
US20100210523A1
Chemistry; metallurgy

Modulation of activity of proneurotrophins

#25 | 2009-04-30
US20090110720A1
Human necessities

Use of compounds for the prevention of drug-induced cell toxicity

#26 | 2007-11-15
US20070264195A1
Chemistry; metallurgy

Modulation of activity of neurotrophins

#27 | 2007-01-04
US20070004727A1
Human necessities

Use of compounds for the prevention of drug-induced cell toxicity

InventorID:

234128